Kestra Medical Technologies Cash Flow Statement (2024-2025) | KMTS

Cash Flow Statement Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025
Operating Activities
Net Income -21.62M-22.28M-20.32M-20.62M-21.76M-51.11M-25.83M-32.78M
Depreciation and Depletion 3.36M3.50M2.38M1.87M1.89M1.84M2.03M2.37M
Share-based Compensation 0.37M0.39M0.38M1.12M0.46M22.31M4.58M8.65M
Gains from Investment Securities 0.02M-0.23M-0.26M-0.33M-0.80M4.03M-2.91M0.84M
Non-cash Items 32.64M23.43M47.34M
Cash from Operations -14.95M-17.50M-18.06M-18.35M-23.70M-26.27M-18.34M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.08M0.23M0.23M0.63M0.24M0.37M0.47M0.47M
Depreciation & Amortization (CF) 3.36M3.50M2.38M1.87M1.89M1.84M2.03M2.37M
Change in Working Capital
Change in Receivables 1.10M2.89M1.58M1.46M2.85M1.78M1.71M
Change in Account Payables 1.62M2.27M-2.61M3.38M-0.20M-2.90M0.52M
Change in Accured Expenses 1.15M0.14M1.65M0.94M1.89M-0.86M1.38M
Other Working Capital Changes 0.12M0.39M-0.27M0.10M1.62M-0.14M-0.81M
Investing Activities
Capital Expenditures 4.11M7.04M4.45M4.06M7.39M8.17M7.26M
Cash from Investing Activities -4.16M-7.03M-4.42M-4.09M-7.76M-8.23M-7.42M
Financing Activities
Other financing activities 0.00M3.22M
Cash from Financing Activities 12.24M116.25M-0.57M-0.12M214.70M-1.88M-0.03M
Additional items
Change in Cash -6.87M91.72M-23.05M-22.57M183.24M-36.38M-25.79M
Beginning Cash Balance 15.35M15.12M8.25M99.97M76.92M54.35M237.59M201.21M
Free Cash Flow -19.06M-24.54M-22.50M-22.42M-31.09M-34.44M-25.61M
Net Cash Flow -6.87M91.72M-23.05M-22.57M183.24M-36.38M-25.79M